Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8223009 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 7 Pages |
Abstract
Patients with oropharyngeal cancer treated with IMRT have excellent disease control. Locoregional recurrence was uncommon, and most often occurred in the high dose volumes. Parotid sparing was accomplished in nearly all patients without compromising tumor coverage.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Adam S. MD, Lei PhD, William H. MD, Erich M. MD, MPH, Bonnie S. MD, Steven J. MD, Beth M. MD, PhD, Gary B. MD, David L. MD, Merill S. MD, Randal S. MD, K. Kian MD, PhD, David I. MD,